Philip Ron Minsider trades

In SEC Form 4 filings, Philip Ron M is listed as Director of City Therapeutics, Inc. (CTY) and Director of Avalo Therapeutics, Inc. (AVTX). Philip Ron M reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 19.

Companies and roles

Company	Role	Transactions	Last filed
CTYCity Therapeutics, Inc.	Director	1	Oct 19
AVTXAvalo Therapeutics, Inc.	Director	1	Oct 2

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CTYCity Therapeutics, Inc.	Oct 15	Oct 19	A · derivative	22,649	$18.00	$407,682	22,649	No	Form 4
AVTXAvalo Therapeutics, Inc.	Sep 30	Oct 2	A · derivative	1,109	$12.29	$13,630	1,109	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.